A recent study has found that a skin ointment containing cannabigerol (CBG) and cannabidiol (CBD) may help ease the symptoms of atopic dermatitis, commonly known as eczema. The research, published in the Clinical, Cosmetic and Investigational Dermatology journal, followed nine adults diagnosed with eczema over three months. The researchers tracked skin health indicators, including moisture levels, oil production, skin pH, and water loss.
Participants used a topical treatment containing 5% CBG, 30% CBD, cholesterol, and hemp seed oil. According to the researchers, applying the ointment daily to affected areas—specifically the forearms—and covering it with a wet wrap before sleep helped improve various skin health markers. These included hydration, oil levels, water loss, and redness.
Some patients even experienced remission of their symptoms. The treatment served as an alternative to more conventional therapies during both flare-ups and periods of remission.
The authors noted better results among participants who consistently followed the application routine. Those who skipped applications or were put off by the greasy feel of the product didn’t experience the same level of improvement.
While the results are promising, the researchers acknowledged that the timing of the study, from May to July of 2022, might have influenced outcomes, since eczema symptoms tend to lessen in warmer months.
This study adds to the growing interest in CBD’s role in skincare. A study from Thailand found that CBD may be useful in cosmetic products thanks to its antioxidant and wound-healing properties. Researchers there suggested that CBD could be added to items like sunscreen, hair products, or healing ointments.
Another study published by a team in the U.S. showed that using CBD-infused lotion might reduce skin damage caused by UV rays. Participants who applied the CBD product experienced less UV-related damage compared to a placebo group.
The potential benefits of cannabinoids may also extend to veterinary care. A 2024 study explored how full-spectrum cannabis oil helped a dog with discoid lupus erythematosus, an autoimmune condition that typically causes hair loss and skin lesions. Traditional steroid treatments had caused liver issues, but switching to cannabis oil—with a CBD to THC ratio of 1:2—led to notable improvement in the dog’s skin and liver health. The dog’s behavior also improved shortly after stopping steroid medication.
Overall, these findings suggest a growing interest in the role of cannabinoids as a potential option for managing various skin conditions in both humans and animals. The findings also show that the full range of therapeutic benefits that can be obtained from the available marijuana products on the market by players like Tilray Brands Inc. (NASDAQ: TLRY) (TSX: TLRY) has yet to be documented by researchers.
About CNW420
CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of an article each business day at 4:20 p.m. Eastern – a tribute to the time synonymous with cannabis culture. The concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.
To receive SMS alerts from CNW, text CANNABIS to 888-902-4192 (U.S. Mobile Phones Only)
For more information, please visit https://www.CannabisNewsWire.com
Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: https://www.CannabisNewsWire.com/Disclaimer
CannabisNewsWire
Denver, CO
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com
CannabisNewsWire is powered by IBN
